IHF
iShares U.S. Healthcare Providers ETF
NYSEArcaUSDETF / FUND
DELAYED
Buy
+28/100
Last price
55.90
▼ 0.14 (0.25%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
56.04
Day high
56.33
Day low
55.61
Volume
579.10K
Market cap
—
P/E (TTM)
20.80
52W range
40.85 – 58.30
Trailing performance
Returnvs SPY
1W
+0.96%
-1.0%
1M
-2.65%
-3.8%
3M
-1.88%
-6.4%
6M
+25.36%
+7.2%
YTD
+16.60%
+2.4%
1Y
+10.37%
-6.1%
3Y
+13.57%
-68.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Top holdings
| Symbol | Name | Weight | |
|---|---|---|---|
| UNH | UnitedHealth Group Inc | 21.72% | |
| CVS | CVS Health Corp | 12.26% | |
| ELV | Elevance Health Inc | 9.42% | |
| VEEV | Veeva Systems Inc Class A | 5.09% | |
| HCA | HCA Healthcare Inc | 4.71% | |
| CI | The Cigna Group | 4.55% | |
| HUM | Humana Inc | 4.44% | |
| CNC | Centene Corp | 4.11% | |
| DGX | Quest Diagnostics Inc | 3.44% | |
| LH | Labcorp Holdings Inc | 3.35% |
Sector exposure
Healthcare
99.69%
Financial services
0.31%
Fund profile
Fund familyiShares
CategoryHealth
Legal typeExchange Traded Fund
Expense ratio0.37%
Turnover37.0%
Total net assets$50.37M
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on IHF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E20.80
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Options analytics
Put / call volume
0.11
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
52.00
-7.0% from spot
ATM implied vol
0.4%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
9
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
56.00
0 contracts
Heaviest put OI
52.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
55.31
+1.06% from price
SMA 20
55.93
-0.05% from price
SMA 50
56.54
-1.14% from price
SMA 100
55.18
+1.30% from price
SMA 200
50.72
+10.21% from price
EMA 12
55.60
+0.54% from price
EMA 26
55.96
-0.11% from price
EMA 50
55.93
-0.06% from price
RSI (14)
49.3
Neutral
MACD (12,26,9)
-0.36
Hist 0.01
ATR (14)
0.76
1.36% of price
Realised vol 30D
13.3%
Annualised
Bollinger upper
57.57
20, 2σ
Bollinger lower
54.28
20, 2σ
50 / 200 cross
Golden
56.54 vs 50.72
Trend bias
Above 200
+10.21%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.39
Less volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
13.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-20.3%
Peak to trough
Max drawdown 5Y
-31.0%
Peak to trough
ATR 14
0.76
1.36% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs
Zacks · 30d ago
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
Zacks · 35d ago
8 ETF Winners in the ‘Pay Me Now’ Trade
Barrons.com · 68d ago
UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch
Zacks · 72d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.